Organ support & nutrition

Extracorporeal CO2 removal integrated with continuous renal replacement therapy in patients with acute respiratory distress syndrome and acute kidney injury: a systematic review and meta-analysis

Ann Intensive CarePublished Systematic review and meta-analysis of observational studies

Authors' conclusion

ECCO2R integrated with CRRT was associated with early PaCO2 reduction, pH improvement, and lower ventilatory intensity in patients with ARDS and AKI.

Study context

Population
Adults with acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT)
Participants
105 adults · 7 observational studies
Comparison
ECCO2R integrated with CRRT, pre vs post treatment initiation
Outcome
Changes in PaCO2 and arterial pH after treatment initiation
Methodological detailspre-post analysis, random-effects models
  • Pre-post analysis
  • Random-effects models

Pooled result

As reported in the abstract

Change in PaCO2 and arterial pH (pre-post)
MD, mmHg (95% CI)
PaCO2 at 2 h
−8.22(−12.00 to −4.44)
PaCO2 at 6 h
−9.02(−15.69 to −2.34)
PaCO2 at 24 h
−9.10(−13.59 to −4.61)
Arterial pH at 2 h
MD + 0.05 (95% CI 0.02–0.08)
Arterial pH at 24 h
MD + 0.06 (95% CI 0.02–0.11)

Further pooled results

Ventilatory variables (pre-post)

MD (mL/kg PBW) (95% CI)
Tidal volume normalized to predicted body weight−1.14 (−1.74 to −0.54)
MD (cmH2O) (95% CI)
Driving pressure−3.61 (−4.87 to −2.35)
MD (J/min) (95% CI)
Mechanical power−6.82 (−9.12 to −4.51)

Safety

Safety and patient-centred outcomes

Limited and heterogeneously reported

Original publication

Extracorporeal CO2 removal integrated with continuous renal replacement therapy in patients with acute respiratory distress syndrome and acute kidney injury: a systematic review and meta-analysis. Ann Intensive Care. Published 15 July 2026. doi:10.1016/j.aicoj.2026.100114

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.